نبذة مختصرة : It is a consensus that obesity in childhood and adolescence has increased significantly in recent decades, making it a worrying case in global health. Obesity is a pathology of the group of Chronic Non-Communicable Diseases (NCDs) which can be defined as a disease characterized by excessive increase in fat (TARDIDO; FALCÃO, 2006). Pharmacological therapy is recommended as an adjunct tool for obese or overweight patients who may be associated with life-threatening comorbidities. Anti-obesity drugs generally act by decreasing appetite, inhibiting fat absorption or increasing energy consumption and thermogenesis, and also on neurotransmission systems. Among the drugs used as slimming, we can highlight: Sibutramine, Sertraline and Fluoxetine. This article aims to understand the role of the pharmacist, given the situation of their client-patient in the use of sibutramine, thus contributing to a better control and dosage of appetite, bringing satisfactory results to combat obesity. The benefits of using pharmacological agents are to promote increased patient adherence to nutritional and behavioral changes, in addition to weight loss and improved life. For that, a descriptive research with a qualitative approach of literature review was used. ; Existe un consenso de que la obesidad en la infancia y la adolescencia ha aumentado significativamente en las últimas décadas, lo que la convierte en un caso preocupante en la salud global. La obesidad es una patología del grupo de las Enfermedades Crónicas No Transmisibles (ENT) que se puede definir como una enfermedad caracterizada por un aumento excesivo de grasa. La terapia farmacológica se recomienda como una herramienta complementaria para pacientes obesos o con sobrepeso, que pueden estar asociados con comorbilidades potencialmente mortales. Los medicamentos contra la obesidad generalmente actúan disminuyendo el apetito, inhibiendo la absorción de grasas o aumentando el consumo de energía y la termogénesis, y también sobre los sistemas de neurotransmisión. Entre los ...
Processing Request
No Comments.